fluvoxamine maleate 100 mg
1 INDICATIONS AND USAGE Fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) ( 1 ). 1.1 Obsessive-Compulsive Disorder Fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD), as defined in DSM-III-R or DSM-IV. The obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. Obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. The efficacy of fluvoxamine maleate tablets was established in four trials in outpatients with OCD: two 10-week trials in adults, one 10-week trial in pediatric patients (ages 8 to 17), and one maintenance trial in adults [see Clinical Studies (14) ] .
upsher-smith laboratories, llc
ROUND BROWN U 672
U 672 ROUND BROWN
Related Pills
fluvoxamine maleate 50 mg
upsher-smith laboratories, llc
fluvoxamine maleate 25 mg
upsher-smith laboratories, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
FLUVOXAMINE MALEATE tablets, USP, for oral administration, are available as: 25 mg: off-white, round, biconvex, film-coated, debossed "U" over "70" on one side and plain on the other side. They are supplied as: Bottles of 100 with a child-resistant closure, NDC 0832-1670-11 50 mg: yellow, round, biconvex, film-coated, debossed "U" over "71" on one side and bisected on the other side. They are supplied as: Bottles of 100 with a child-resistant closure, NDC 0832-1671-11 100 mg: beige, round, biconvex, film-coated, debossed "U" over "672" on one side and bisected on the other side. They are supplied as: Bottles of 100 with a child-resistant closure, NDC 0832-1672-11
FLUVOXAMINE MALEATE tablets, USP should be protected from high humidity and stored at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep out of reach of children.
More pills like ROUND U 672